(Q39341928)

11 September 2017

title

Pentamidine as secondary prophylaxis for visceral leishmaniasis in the immunocompromised host: report of four cases (English)

1 reference

11 September 2017

main subject

visceral leishmaniasis

1 reference

1 reference

T A Patel

1

1 reference

11 September 2017

D N Lockwood

series ordinal

2

1 reference

11 September 2017

publication date

22 June 2009

1 reference

Tropical Medicine and International Health

11 September 2017

published in

1 reference

11 September 2017

volume

14

1 reference

11 September 2017

issue

9

1 reference

11 September 2017

page(s)

1064-1070

1 reference

A policy for leishmaniasis with respect to the prevention and control of drug resistance

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2009.02329.X

Disseminated cutaneous leishmaniasis after visceral disease in a patient with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2009.02329.X

Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2009.02329.X

Treatment options for visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2009.02329.X

Is leishmaniasis ever cured?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2009.02329.X

Leishmania/HIV co-infections: epidemiology in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2009.02329.X

Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2009.02329.X

Visceral leishmaniasis in patients infected with the human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2009.02329.X

The impact of highly active antiretroviral therapy (HAART) on visceral leishmaniasis in Spanish patients who are co-infected with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2009.02329.X

Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2009.02329.X

Treatment of visceral leishmaniasis in a patient with AIDS with antimony and gamma-interferon: remission and prevention of relapse by maintenance therapy with weekly pentamidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2009.02329.X

Long-term remission of human immunodeficiency virus-associated visceral leishmaniasis after initiation of potent combination antiretroviral treatment: report of two cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2009.02329.X

Visceral leishmaniasis in patients infected with human immunodeficiency virus. Co-operative Group for the Study of Leishmaniasis in AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2009.02329.X

Liposomal amphotericin B in secondary prophylaxis of visceral leishmaniasis in HIV-infected patients: report of five clinical cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2009.02329.X

Leishmaniasis as an opportunistic infection in HIV-infected patients: determinants of relapse and mortality in a collaborative study of 228 episodes in a Mediterreanean region

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2009.02329.X

Visceral leishmaniasis in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients. A comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2009.02329.X

Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2009.02329.X

Clinical manifestations of visceral leishmaniasis associated with HIV infection: a retrospective study of 91 French cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2009.02329.X

Visceral leishmaniasis and HIV-1 co-infection in southern France

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2009.02329.X

Highly Active Antiretroviral Therapy (HAART) Modifies the Incidence and Outcome of Visceral Leishmaniasis in HIV-Infected Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2009.02329.X

10.1111/J.1365-3156.2009.02329.X

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference